Chemo-Click: Receptor-Controlled and Bioorthogonal Chemokine Ligation for Real-Time Imaging of Drug-Resistant Leukemic B Cells
Journal of the American Chemical Society · 2024
DOI: 10.1021/jacs.4c12035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2024. Verfasst von Marco Bertolini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Inflammation Research, The University of Edinburgh, Edinburgh EH16 4UU, U.K. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, H2020 Marie Sklodowska-Curie Actions, H2020 European Research Council.
Abstract (Originalsprache)
Drug resistance in B cell leukemia is characterized by the coexpression of CXCR5 and CXCR3 chemokine receptors, making it a valuable biomarker for patient stratification. Herein, we report a novel platform of activatable chemokines to selectively image drug-resistant leukemic B cells for the first time. The C-terminal derivatization of the human chemokines CXCL13 and CXCL10 with bioorthogonal tetrazine-BODIPY and BCN groups retained binding and internalization via their cognate CXCR5 and CXCR3 receptors and enabled rapid fluorescence labeling of CXCR5+ CXCR3+ resistant B cells─but not drug-susceptible leukemic cells─via intracellular chemokine ligation. This modular chemical approach offers a versatile strategy for real-time immunophenotyping of cell populations with distinct chemokine profiles and will accelerate the design of new precision medicine tools to advance personalized therapies in blood tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Inflammation Research, The University of Edinburgh, Edinburgh EH16 4UU, U.K.
- IRR Chemistry Hub, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh EH16 4UU, U.K.
ORCID-Profile: Marco Bertolini, Marc Vendrell
Förderung
- European Research Council
- H2020 Marie Sklodowska-Curie Actions
- H2020 European Research Council
Zitieren
APA
Bertolini, M., Mendive-Tapia, L., Karmakar, U., & Vendrell, M. (2024). Chemo-Click: Receptor-Controlled and Bioorthogonal Chemokine Ligation for Real-Time Imaging of Drug-Resistant Leukemic B Cells. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.4c12035
Vancouver
Bertolini M, Mendive-Tapia L, Karmakar U, Vendrell M. Chemo-Click: Receptor-Controlled and Bioorthogonal Chemokine Ligation for Real-Time Imaging of Drug-Resistant Leukemic B Cells. Journal of the American Chemical Society. 2024. doi:10.1021/jacs.4c12035
BibTeX
@article{Bertolini2024,
author = {Bertolini, Marco and Mendive-Tapia, Lorena and Karmakar, Utsa and Vendrell, Marc},
title = {Chemo-Click: Receptor-Controlled and Bioorthogonal Chemokine Ligation for Real-Time Imaging of Drug-Resistant Leukemic B Cells},
journal = {Journal of the American Chemical Society},
year = {2024},
doi = {10.1021/jacs.4c12035}
}
EUVIMED